Uncategorized
Novaliq GmbH Announces Licensing Agreement with AFT Pharmaceuticals for the Distribution of NovaTears®
HEIDELBERG, Germany--(BUSINESS WIRE)--#MGD--Novaliq GmbH announced a strategic licensing agreement with AFT Pharmaceuticals for the commercialization of Novaliq’s lead product NovaTears® in Australia and New Zealand.